Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
Google Scholar
Kim, D. et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520, 363–367 (2015).
Google Scholar
Carlisle, A. E. et al. Selenium detoxification is required for cancer-cell survival. Nat. Metab. 2, 603–611 (2020).
Google Scholar
Spears, M. E. et al. De novo sphingolipid biosynthesis necessitates detoxification in cancer cells. Cell Rep. 40, 111415 (2022).
Google Scholar
Lee, N., Spears, M. E., Carlisle, A. E. & Kim, D. Endogenous toxic metabolites and implications in cancer therapy. Oncogene 39, 5709–5720 (2020).
Google Scholar
Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779–1784 (2017).
Google Scholar
Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012).
Google Scholar
Axelrod, J., Kalckar, H. M., Maxwell, E. S. & Strominger, J. L. Enzymatic formation of uridine diphosphoglucuronic acid. J. Biol. Chem. 224, 79–90 (1957).
Google Scholar
Prydz, K. & Dalen, K. T. Synthesis and sorting of proteoglycans. J. Cell Sci. 113, 193–205 (2000).
Google Scholar
Mulder, G. J. Glucuronidation and its role in regulation of biological activity of drugs. Annu. Rev. Pharmacol. Toxicol. 32, 25–49 (1992).
Google Scholar
Moriarity, J. L. et al. UDP-glucuronate decarboxylase, a key enzyme in proteoglycan synthesis: cloning, characterization, and localization. J. Biol. Chem. 277, 16968–16975 (2002).
Google Scholar
Kakizaki, I. et al. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J. Biol. Chem. 279, 33281–33289 (2004).
Google Scholar
Kultti, A. et al. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp. Cell. Res. 315, 1914–1923 (2009).
Google Scholar
Clarkin, C. E., Allen, S., Wheeler-Jones, C. P., Bastow, E. R. & Pitsillides, A. A. Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenase. Matrix Biol. 30, 163–168 (2011).
Google Scholar
Kjellén, L. & Lindahl, U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60, 443–475 (1991).
Google Scholar
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).
Google Scholar
Vitale, D. et al. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance. FEBS J. 286, 2870–2882 (2019).
Google Scholar
Neufeld, E. F. & Hall, C. W. Inhibition of UDP-D-glucose dehydrogenase by UDP-D-xylose: a possible regulatory mechanism. Biochem. Biophys. Res. Commun. 19, 456–461 (1965).
Google Scholar
Gainey, P. A. & Phelps, C. F. Interactions of uridine diphosphate glucose dehydrogenase with the inhibitor uridine diphosphate xylose. Biochem. J 145, 129–134 (1975).
Google Scholar
Beattie, N. R., Keul, N. D., Sidlo, A. M. & Wood, Z. A. Allostery and hysteresis are coupled in human UDP-glucose dehydrogenase. Biochemistry 56, 202–211 (2017).
Google Scholar
Reiling, J. H. et al. A CREB3–ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens. Nat. Cell Biol. 15, 1473–1485 (2013).
Google Scholar
Ignashkova, T. I. et al. Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress-inducing agents. Traffic 18, 530–544 (2017).
Google Scholar
Hiraoka, S. et al. Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human. Nat. Med. 13, 1363–1367 (2007).
Google Scholar
Stanley, P. Golgi glycosylation. Cold Spring Harb. Perspect. Biol. 3, a005199 (2011).
Google Scholar
Varki, A. Factors controlling the glycosylation potential of the Golgi apparatus. Trends Cell Biol. 8, 34–40 (1998).
Google Scholar
Tarentino, A. L., Gomez, C. M. & Plummer, T. H. Jr Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry 24, 4665–4671 (1985).
Google Scholar
Unal, E. S., Zhao, R., Qiu, A. & Goldman, I. D. N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT). Biochim. Biophys. Acta 1778, 1407–1414 (2008).
Google Scholar
Contessa, J. N., Bhojani, M. S., Freeze, H. H., Rehemtulla, A. & Lawrence, T. S. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res. 68, 3803–3809 (2008).
Google Scholar
Ornitz, D. M. & Itoh, N. The fibroblast growth factor signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 4, 215–266 (2015).
Google Scholar
Hakuno, F. & Takahashi, S.-I. IGF1 receptor signaling pathways. J. Mol. Endocrinol. 61, T69–T86 (2018).
Google Scholar
Ouhtit, A., Rizeq, B., Saleh, H. A., Rahman, M. M. & Zayed, H. Novel CD44-downstream signaling pathways mediating breast tumor invasion. Int. J. Biol. Sci. 14, 1782–1790 (2018).
Google Scholar
Normanno, N. et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2–16 (2006).
Google Scholar
Jayaprakash, N. G. & Surolia, A. Role of glycosylation in nucleating protein folding and stability. Biochem. J. 474, 2333–2347 (2017).
Google Scholar
Lis, H. & Sharon, N. Protein glycosylation. Structural and functional aspects. Eur. J. Biochem. 218, 1–27 (1993).
Google Scholar
Taylor, E. S., Pol-Fachin, L., Lins, R. D. & Lower, S. K. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding. Proteins 85, 561–570 (2017).
Google Scholar
Saha, S. et al. UDP-glucose 6-dehydrogenase expression as a predictor of survival in patients with pulmonary adenocarcinoma. Int. J. Surg. Oncol. 5, e85 (2020).
Hagiuda, D. et al. Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma. Biomed. Res. 40, 17–27 (2019).
Google Scholar
Arnold, J. M. et al. UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression. Oncogene 39, 3089–3101 (2020).
Google Scholar
Teoh, S. T., Ogrodzinski, M. P. & Lunt, S. Y. UDP-glucose 6-dehydrogenase knockout impairs migration and decreases in vivo metastatic ability of breast cancer cells. Cancer Lett. 492, 21–30 (2020).
Google Scholar
Lin, L.-H. et al. Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis. J. Cell. Mol. Med. 24, 11883–11902 (2020).
Google Scholar
Tang, T. et al. A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 28, 749–755 (2010).
Google Scholar
Vitale, D. L. et al. Initial identification of UDP-glucose dehydrogenase as a prognostic marker in breast cancer patients, which facilitates epirubicin resistance and regulates hyaluronan synthesis in MDA-MB-231 cells. Biomolecules 11, 246 (2021).
Google Scholar
Ahmed, N. et al. Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells. Sci. Rep. 6, 30061 (2016).
Google Scholar
Paul, D. et al. Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma. J. Proteomics 138, 95–105 (2016).
Google Scholar
Radominska-Pandya, A., Bratton, S. M., Redinbo, M. R. & Miley, M. J. The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families. Drug Metab. Rev. 42, 133–144 (2010).
Google Scholar
Mackenzie, P. I. et al. Regulation of UDP glucuronosyltransferase genes. Curr. Drug Metab. 4, 249–257 (2003).
Google Scholar
Nagar, S. & Blanchard, R. L. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab. Rev. 38, 393–409 (2006).
Google Scholar
Corsello, S. M. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer 1, 235–248 (2020).
Google Scholar
Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343, 80–84 (2014).
Google Scholar
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
Google Scholar
Barger, C. J., Branick, C., Chee, L. & Karpf, A. R. Pan-cancer analyses reveal genomic features of FOXM1 overexpression in cancer. Cancers 11, 251 (2019).
Google Scholar
Nonnenmacher, Y. et al. Analysis of mitochondrial metabolism in situ: Combining stable isotope labeling with selective permeabilization. Metab. Eng. 43, 147–155 (2017).
Google Scholar
Vercesi, A. E., Bernardes, C. F., Hoffmann, M. E., Gadelha, F. R. & Docampo, R. Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in situ. J. Biol. Chem. 266, 14431–14434 (1991).
Google Scholar
Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373–386 (2018).
Google Scholar
Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98–W102 (2017).
Google Scholar